Indian pharma sees immense importance in US FDA guidance on aluminum content and labelling in parenteral nutrition
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 12, 2023
Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharma companies in the country have increasingly made a shift to nutritional based prescription and over the counter products.
Let's personalize your content